SU2C Lung Cancer Early Detection Challenge Grants
SU2C Lung Cancer Early Detection Challenge Grants support researchers evaluating non-DNA, non-blood detection platforms to find lung cancer before treatment and improve outcomes in smokers.
Browse similar grants
Funder: Stand Up To Cancer
Due Dates: Not specified
Funding Amounts: Award amount and duration not specified
Summary: Supports evaluation of alternatives to DNA-based and blood-based assays for detecting lung cancer before treatment and improving outcomes in smokers.
Key Information: Applications should propose non-DNA-based, non-blood-based detection modalities.
Description
Stand Up To Cancer (SU2C) supports evaluation of different platforms for the early detection of lung cancer before treatment, with the goal of improving outcomes in smokers. The challenge focuses on alternatives to DNA-based and blood-based assays. Examples include RNA in saliva, protein analytes in urine, and volatile organic compounds (VOCs) from breath.
The opportunity is part of SU2C’s broader support for individual investigators and collaborative teams addressing critical problems in cancer patient care and delivering near-term patient benefits. SU2C encourages novel, collaborative, high-impact proposals. Its funding approach emphasizes innovation, information sharing, health equity, and goal-oriented research with defined milestones and deliverables.
